AstraZeneca’s Imfinzi increases survival rates in bladder cancer
BARCELONA, Spain — An AstraZeneca immunotherapy, given both before and after surgery, improved survival rates in patients with bladder cancer, ...
BARCELONA, Spain — An AstraZeneca immunotherapy, given both before and after surgery, improved survival rates in patients with bladder cancer, ...
BARCELONA, Spain — A widely used immunotherapy approach helped stave off disease progression in patients with a type of anal ...
Cancers of the head and neck can be treated with several drugs on the market, but for certain patients diagnosed ...
Credit: Unsplash/CC0 Public Domain A team of researchers at IRB Barcelona has identified five independent factors that predict cancer patients' ...
Cancer diagnoses in the United States dropped almost 10% below expected rates in 2020 as people missed annual screenings, and ...
Prostate cancer cells. Credit: NIH Image Gallery Researchers at the University of Michigan Health Rogel Cancer Center have uncovered a ...
The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project ...
A study today in JAMA Network Open reveals that several counties in north Texas have a higher incidence of human papillomavirus (HPV)-related ...
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.